Skip to main content
. 2017 May;15(3):262–271. doi: 10.1370/afm.2031

Table 2.

Randomized Clinical Trials to Prevent Depression in Primary Care

Author, Year Country Target Population, Type of Prevention Inclusion Criteria Sample (Control/Intervention) No. Care Management Intervention Orientation (No. of Sessions/Format) Clinician Main Outcome Follow-up Risk of Biasa
Barrett et al,49 2001b (United States) Adults (18–59 y)
Indicatedc
Minor depression (HRSD ≥10; PRIME-MD) 74 (38/36) 1. PST-PC
2. Placebo plus clinical management
CB (6/individual) Psychologists Depressive symptoms (HSCL-D-20 depression scale) 11 wk 1 (llulll)
Bellón et al,47 2016 (Spain) Adults (18–75 y)
Universald
No MD in past 6 mo (CIDI) 3,326 (1,663/1,663) 1. Biopsychosocial intervention
2. CAU
Biopsychosocial personalized (3/individual) Primary care physicians who received a 10- to 15-h training workshop Incidence MD (CIDI) 6-12-18 mo 2 (llhlll)
Brugha et al,44 2011 (United Kingdom) Women postnatally
Selectivee
No depression (EPDS <12) 2,241 (767/1,474) 1. CBA/PCA
2. CAU
CBA/PCA (8/individual) Community nurse (health visitor) with 6 half-days training and access to regular supervision sessions Proportion of women scoring ≥12 EPDS 6-12-18 mo 5 (luhhll)
Brugha et al,45 2016 (United Kingdom) Pregnant women
Selectivee
No depression (EPDS <12) 186 (83/103) 1. CBA
2. CAU
CBA (3/individual) Community midwife with 8-d training in psychological care (1 d exclusively in the use of the EPDS) Proportion of women scoring ≥12 EPDS 22 wk 4 (llhlhl)
Frank et al,38 2002b (United States) Adults (≥18 y)
Indicatedc
Minor depression (HRSD ≥10; PRIME-MD) 168 (89/79) 1. PST-PC
2. Placebo plus clinical management
CB (6/individual) Psychologists, social workers, counselors Depressive symptoms (HSCL-D-20 depression scale) 11 wk 3 (llulhl)
García-Campayo et al,43 2010 (Spain) Adults (18–65 y)
Selectivee
No DSM-IV Axis I psychiatric disorders (SPPI) 104 (52/52) 1. Psychoeducational
2. No intervention
Psychoeducational and CB (5/group) Primary care physicians with specific training in mental health and group therapy Prevalence of somatoform disorders (SPPI) 3-6-60 mo 3 (llhlul)
Gillham et al,40 2006 (United States) Early adolescents (11–12 y)
Indicatedc
No MD (CDI ≥7/9; DICA-R) 271 (124/147) 1. CBT (PRP)
2. CAU
CB (12/group) Child psychologists, child social workers Depressive symptoms (CDI) 6-12-18-24 mo 7 (lhhhul)
González et al,50 2006 (Spain) Adults (25–55 y)
Indicatedc
No depressive disorder (DSM-IV) 60 (NR/NR) 1. CBT
2. Encouraging personal resources
3. Social support
4. Waiting list
CB (6/group) Psychologists Depressive symptoms (BDI) 6-12 mo 9 (uhhhhl)
Lynch et al,37 1997 (United States) Adults (≥18 y)
Indicatedc
Minor depression (MOS Depression Screening Inventory >cutoff; DIS) 29 (14/15) 1. PST
2. CAU
CB (6/individual by telephone) Student therapist, medical student, graduate nursing student Depressive symptoms (BDI) 7 wk 7 (uhhlhl)
Muñoz et al,36 1993–1995 (United States) Adults (≥18 y)
Selectivee
No MD in past 6 months (DIS) 150 (78/72) 1. CBT
2. No intervention or information by videotape
CB (8/group) Psychologists Incidence of depression (DIS), depressive symptoms (BDI, CES-D) 6-12 mo 2 (llhlll)
van’t Veer-Tazelaar et al,41,42 2009–2011f (the Netherlands) Elderly (≥75 y)
Indicatedc
Subthreshold depressive symptoms, no MDE (CES-D ≥16; MINI) 170 (84/86) 1. Stepped-care program
2. CAU
CB (10/individual) Home care nurse, specially trained (CBT-bibliotherapy), community psychiatric nurse (CBT + PST), primary care physician to give psychotropic medication (only for participants with continuously elevated CES-D scores) Cumulative incidence of MDD (MINI) 6-12-24 mo 4 (lhhlll)
Willemse et al,39 2004 (the Netherlands) Adults (18–65 y)
Indicatedc
Subthreshold depression, no MDD in past 12 mo (CIDI) 216 (109/107) 1. CBT
2. CAU
CB (CWD) (7/individual) Prevention specialist, clinician from a community mental health center Incidence of depression (CIDI), depressive symptoms (CES-D) 12 mo 4 (lhhlll)
Williams et al,48 2000b (United States) Older adults (≥60 y)
Indicatedc
Minor depression (HRSD ≥10; PRIME-MD) 130 (67/63) 1. PST-PC
2. Placebo plus clinical management
CB (6/individual) Psychologists, social workers, counselors Depressive symptoms (HSCL-D-20 depression scale) 11 wk 1 (llulll)
Zhang et al,46 2014f (China) Adults (≥18 y)
Indicatedc
Subthreshold depression, no MD (CES-D ≥16; SCID) 240 (119/121) 1. Stepped-care program
2. CAU
CB (12/individual) Social workers with at least 3 y counseling experience, primary care physician to give psychotropic medication (only for participants with continuously elevated CES-D scores) or referred to see a psychiatrist Incidence MD (SCID), depressive symptoms (CES-D) 3-6-9-12-15 mo 3 (llhlul)

BDI = Beck Depression Inventory; CAU = care as usual; CB = cognitive behavioral; CBA = cognitive behavioral approach; CBT = cognitive behavioral therapy; CDI = Children’s Depression Inventory; CES-D = Center for Epidemiologic Studies of Depression; CIDI = Composite International Diagnostic Interview; DICA-R = Diagnostic Inventory for Children and Adolescents; DIS = Diagnostic Interview Schedule; DSM = Diagnostic and Statistical Manual of Mental Disorders; EPDS = Edinburgh Postnatal Depression Scale; HDRS = Hamilton Depression Rating Scale; HSCL-D = Hopkins Symptom Checklist for Depression; MD = major depression; MDD = major depressive disorder; MDE = major depressive episode; MINI = Mini International Neuropsychiatric Interview; MOS = Medical Outcome Study; NR = not reported; PCA = person centered approach; PRIME-MD = The Primary Care Evaluation of Mental Disorders; PRP = Penn Resiliency Program; PST = problem solving therapy; PST-PC = problem solving treatment for primary care; SCID = Structured Clinical Interview for DSM-IV; SPPI = Standardized Polyvalent Psychiatric Interview.

Note: CB, CBA, and CBT focus on the development of personal coping strategies that target solving current problems and changing unhelpful patterns in cognitions (eg, thoughts, beliefs, and attitudes), behaviors, and emotional regulation.

a

High score means higher risk of bias. Low risk (l) = 0 points; unclear risk (u) = 1 point; or high risk (h) = 2 points; indicate rating of 6 quality criteria: random sequence, allocation concealment, blinding of participants and clinicians, blinding of outcome assessment, incomplete outcome data, selective reporting.

b

These studies had 3 arms (paroxetine, placebo and problem-solving therapy), but we only used placebo vs problem-solving therapy.

c

Patients with minor or subthreshold depression.

d

General population.

e

Patients with some risk factors for depression.

f

In these studies, we collected only depression data.